Eli Lilly and Company

01/15/2025 | Press release | Distributed by Public on 01/15/2025 15:07

FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease